Skip to main content
. 2019 Aug 2;8(2):283–295. doi: 10.1007/s40119-019-00146-6

Table 4.

Association of patient satisfaction scales at 4 weeks with subsequent early study drug discontinuation

Questionnaire/Scale Cut-offa Not satisfiedb Satisfiedb HR (95% CI)c Not satisfied vs. satisfied P valuec
ACTS
 Burdens
  N 42 29 1152
  Events/100 pt-years (total events) 6.89 (4) 5.41 (112) 1.44 (0.44–3.46) 0.50
 Benefits
  N 12 462 719
  Events/100 pt-years (total events) 6.02 (51) 5.07 (65) 1.18 (0.81–1.71) 0.38
TSQM II
 Effectiveness
  N 67 195 986
  Events/100 pt-years (total events) 7.00 (23) 5.16 (93) 1.23 (0.76–1.91) 0.38
 Side Effects
  N 100 326 855
  Events/100 pt-years (total events) 5.55 (31) 5.41 (85) 0.99 (0.64–1.48) 0.95
Convenience
  N 67 98 1083
  Events/100 pt-years (total events) 4.61 (8) 5.52 (108) 0.77 (0.34–1.48) 0.48
Global Satisfaction
  N 67 149 1032
  Events/100 pt-years (total events) 5.32 (14) 5.47 (102) 0.95 (0.52–1.61) 0.86

ACTS Anti-Clot Treatment Scale, CI confidence interval, HR hazard ratio, TSQM II Treatment Satisfaction Questionnaire for Medication version II

aSatisfaction is defined as a score at or above the cut-off

bGroups are defined using “satisfied” or “not satisfied” survey answers (primary analysis; see Methods)

cHazard ratio and P value for discontinuation are from adjusted model